The current work uncovers that ZDHHC3‐induced palmitoylation is a novel regulatory mechanism and signal that regulates IRHOM2 trafficking, which confers evidence associating the regulation of palmitoylation with NASH progression. Here, ZDHHC3 is linked to metabolic dysfunction-associated steatohepatitis.